178 related articles for article (PubMed ID: 17059782)
1. [Meta-analysis of postoperative adjuvant chemotherapy for localized esophageal carcinoma].
Huang WZ; Fu JH; Hu Y; Zhang X; Yang H
Ai Zheng; 2006 Oct; 25(10):1303-6. PubMed ID: 17059782
[TBL] [Abstract][Full Text] [Related]
2. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.
Ando N; Iizuka T; Ide H; Ishida K; Shinoda M; Nishimaki T; Takiyama W; Watanabe H; Isono K; Aoyama N; Makuuchi H; Tanaka O; Yamana H; Ikeuchi S; Kabuto T; Nagai K; Shimada Y; Kinjo Y; Fukuda H;
J Clin Oncol; 2003 Dec; 21(24):4592-6. PubMed ID: 14673047
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
4. [The value of postoperative arterial infusion chemotherapy in patients with T3 esophageal squamous carcinoma after radical surgery].
Liu BD; Zhi XY; Xu QS
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):586-9. PubMed ID: 15949351
[TBL] [Abstract][Full Text] [Related]
5. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
Mariette C; Taillier G; Van Seuningen I; Triboulet JP
Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
[TBL] [Abstract][Full Text] [Related]
7. [Postoperative adjuvant therapies for esophageal carcinoma].
Kuwano H; Ojima H; Kato H
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2023-7. PubMed ID: 11103232
[TBL] [Abstract][Full Text] [Related]
8. [Results of preoperative radio-chemotherapy in locally advanced squamous epithelial cancer of the esophagus].
Nürnberger HR; Löffler T; Hausamen TU; Theophil B; Löhlein D
Chirurg; 1993 Sep; 64(9):701-7; discussion 707-8. PubMed ID: 8222927
[TBL] [Abstract][Full Text] [Related]
9. [Progress of postoperative adjuvant therapies for esophageal cancer].
Terashima M; Kogure M; Gotoh M
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2475-80. PubMed ID: 12506469
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of low-dose cisplatin and 5-fluorouracil as adjuvant chemoradiotherapy for advanced squamous cell carcinoma of the esophagus.
Shimizu K; Hihara J; Yoshida K; Toge T
Hiroshima J Med Sci; 2005 Sep; 54(3):67-71. PubMed ID: 16180698
[TBL] [Abstract][Full Text] [Related]
11. [Perioperative chemotherapy of squamous cell cancer of the esophagus].
Fink U; Pfeiffer G; Gossmann A; Preusser P; Wilke HJ; Siewert JR
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():107-10. PubMed ID: 1983489
[TBL] [Abstract][Full Text] [Related]
12. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
[TBL] [Abstract][Full Text] [Related]
13. [Squamous cell cancer of the esophagus. Treatment concept at the Houston M.D. Anderson Cancer Center].
Roth JA
Chirurg; 1992 Sep; 63(9):683-8. PubMed ID: 1395872
[No Abstract] [Full Text] [Related]
14. Post-operative chemotherapy improves disease-free survival, but not overall survival in people with oesophageal squamous cell carcinoma.
Leonard GD; Reilly EM
Cancer Treat Rev; 2004 Aug; 30(5):473-7. PubMed ID: 15245779
[No Abstract] [Full Text] [Related]
15. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
Msika S; Hay JM
J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
[TBL] [Abstract][Full Text] [Related]
16. [The effect of postoperative chemotherapy after esophagectomy on the survival rate to patients with original squamous cell carcinoma of esophagus].
Liu J; Wang YK; Liu Y; Zhang L; Chen JH; Zheng W
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Apr; 25(4):346-50. PubMed ID: 15231207
[TBL] [Abstract][Full Text] [Related]
17. [Surgical adjuvant therapy of carcinoma of the thoracic esophagus].
Kakegawa T; Yamana H; Fujita H; Shinozaki K
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1173-8. PubMed ID: 8333745
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
Strickland AH; Karapetis CS; Yip D; Harper PG
Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
[No Abstract] [Full Text] [Related]
19. [Neoadjuvant treatment of operable esophageal cancers].
Azria D; Ychou M; Senesse P; Dubois JB
Gastroenterol Clin Biol; 1999 Oct; 23(10):1107-8. PubMed ID: 10592891
[No Abstract] [Full Text] [Related]
20. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study.
Ando N; Iizuka T; Kakegawa T; Isono K; Watanabe H; Ide H; Tanaka O; Shinoda M; Takiyama W; Arimori M; Ishida K; Tsugane S
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):205-9. PubMed ID: 9270637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
